← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
51	PTE 51 DELISTED PolarityTE, Inc. Common Stock PTE	52	-13	-20%	$8.3M
52	52 Autolus Therapeutics AUTL $458M	50	-1	-2%	$230M
53	53 DELISTED Generation Bio GBIO	48	+48	–	$581M
54	LOGC 54 DELISTED LogicBio Therapeutics, Inc. Common Stock LOGC	43	0	0%	$97.7M
55	55 Mesoblast MESO $1.81B	43	+9	+26%	$32.1M
56	56 Celularity CELU $43.2M	42	+7	+20%	$209M
57	57 DELISTED Carisma Therapeutics CARM	40	+4	+11%	$13.5M
58	58 DELISTED Orgenesis Inc. Common Stock ORGS	40	+24	+150%	$27.5M
59	SIOX 59 DELISTED Sio Gene Therapies Inc. Common Stock SIOX	40	-2	-5%	$33.7M
60	60 Imunon IMNN $5.95M	37	+18	+95%	$15.2M
61	61 Capricor Therapeutics CAPR $423M	33	+15	+83%	$4.32M
62	62 Lunai Bioworks LNAI $3.74M	33	+1	+3%	$10.4M
63	63 Immatics IMTX $1.09B	32	+5	+19%	$143M
64	64 Genprex GNPX $1.88M	29	+20	+222%	$15.9M
65	BLCM 65 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	27	-2	-7%	$7.68M
66	GMDA 66 DELISTED Gamida Cell Ltd. Ordinary Shares GMDA	27	+14	+108%	$73.3M
67	67 Ocugen OCGN $276M	21	+5	+31%	$577K
68	68 INmune Bio INMB $45.8M	16	+3	+23%	$1.88M
69	ONCS 69 DELISTED OncoSec Medical Incorporated ONCS	16	-4	-20%	$1.89M
70	70 DELISTED Scorpius Holdings, Inc. SCPX	15	+6	+67%	$8.84M
71	71 Opus Genetics IRD $337M	14	-3	-18%	$898K
72	72 BioCardia BCDA $14.2M	12	+5	+71%	$2.85M
73	CYAD 73 DELISTED Celyad Oncology SA American Depositary Shares CYAD	9	+1	+13%	$9.23M
74	74 Enlivex Ltd ENLV $4.46M	7	+1	+17%	$1.8M
75	75 Eterna Therapeutics ERNA $2.53M	6	-1	-14%	$499K